Precise Biometrics announces outcome of the r...

Precise Biometrics raises SEK 100 million, with nearly half of shares taken up by guarantors.

What the company is saying

Precise Biometrics AB reports the final outcome of its SEK 110.3 million rights issue, resolved by the board on 20 July 2026. The company details that 43.5% of shares were subscribed via rights and 3.4% without rights, with 43.8% allocated to guarantee underwriters. The announcement frames the capital raise as successful by highlighting the total SEK 100 million gross proceeds before costs. The language is factual and procedural, with no claims about future operational use or impact of the funds. Emphasis is placed on the mechanics of the transaction—subscription rates, share capital increase, and timetable for new share trading—while omitting any discussion of strategic rationale or deployment of proceeds. The tone is neutral, offering no forward-looking statements about company growth or profitability.

What the data suggests

The rights issue resulted in 121,951,219 new ordinary shares at SEK 0.82 per share, raising SEK 100 million before transaction costs. Of the shares offered, 43.5% were taken up by existing shareholders exercising rights, 3.4% by others, and 43.8% were allocated to parties with guarantee commitments, indicating limited direct shareholder demand. The capital increase of SEK 36,585,365.70 will bring share capital to SEK 80,606,288.70. The total share count rises to 268,687,629, but the starting figure of 146,736,410 shares is not directly reconciled in the disclosure. The announcement also references 1,855,541,003 outstanding Substitute Warrants, but provides no reconciliation or context for this figure. No operational, revenue, or profit data is disclosed, so the financial trajectory beyond the capital inflow remains unclear. The disclosure is detailed on the transaction itself but omits broader financial context.

Analysis

The announcement is a factual disclosure of the outcome of a rights issue, providing detailed figures on shares subscribed, allocation, and capital raised. The language is neutral and procedural, with no promotional or exaggerated claims about future performance or operational impact. Most statements are realised facts (e.g., subscription results, share capital increase), with only a few forward-looking elements related to the technical settlement and potential exercise of warrants. There is no discussion of how the raised capital will be used, nor any projections of financial or operational benefits, which keeps the narrative grounded. No profitability or operational metrics are disclosed, but this is typical for a capital raise outcome announcement and does not constitute hype. The gap between narrative and evidence is minimal, as all key claims are supported by numerical data.

Risk flags

• ●A large portion of the rights issue (43.8%) was allocated to guarantors, indicating weak take-up by existing shareholders and limited market appetite for the new shares. This matters because it can signal a lack of confidence in the company's near-term prospects or valuation.
• ●The announcement does not disclose how the SEK 100 million in proceeds will be used, leaving investors without visibility into whether the capital will support growth, cover losses, or simply shore up the balance sheet. Lack of deployment detail increases uncertainty about future returns.
• ●There is no reconciliation of the starting and ending share count or of the Substitute Warrants figure, which reduces transparency and makes it difficult to assess dilution risk and the true post-transaction capital structure.

Bottom line

Precise Biometrics has completed a SEK 100 million rights issue, but nearly half of the shares were placed with guarantors rather than taken up by existing or new investors, reflecting tepid demand. The company provides full transparency on the mechanics of the capital raise but omits any discussion of how the funds will be used or what operational impact is expected. No financial or operational performance data is disclosed, so the announcement offers no insight into the company's underlying trajectory or prospects. The lack of detail on capital deployment and the high reliance on underwriters are negative signals for investors seeking clarity or growth catalysts. For this announcement to be actionable, the company would need to specify how the new capital will drive value and provide supporting operational or financial targets. The key takeaway is that while the rights issue delivers immediate liquidity, the absence of a strategic narrative or deployment plan limits its investment relevance.

Announcement summary

(LSE/AIM:0JDU) Precise Biometrics AB announces the outcome of the rights issue of approximately SEK 110.3 million, resolved by the Board of Directors on 20 July 2026. The subscription period in the Rights Issue ended on 12 August 2026. A total of 58,562,361 ordinary shares, corresponding to approximately 43.5 percent of the Rights Issue, were subscribed for by exercise of subscription rights, and 4,533,661 ordinary shares, corresponding to approximately 3.4 percent of the Rights Issue, were subscribed for without subscription rights. 58,855,197 shares, corresponding to approximately 43.8 percent of the Rights Issue, will be allocated to parties that have entered into guarantee commitments. The Rights Issue will provide the Company with SEK 100 million before deduction of transaction costs related to the Rights Issue. The subscription price in the Rights Issue was SEK 0.82 per share. Through the Rights Issue, the share capital will be increased by SEK 36,585,365.70, from SEK 44,020,923 to SEK 80,606,288.70, by a new issue of 121,951,219 new ordinary shares.

Disagree with this article?